Kallikrein Protects Against Ischemic Stroke by Inhibiting Apoptosis and Inflammation and Promoting Angiogenesis and Neurogenesis
- 23 January 2006
- journal article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- External Carotid Artery Territory Ischemia Impairs Outcome in the Endovascular Filament Model of Middle Cerebral Artery Occlusion in RatsStroke, 2003
- Short-term, intermediate-term, and long-term mortality in patients hospitalized for strokeJournal of Clinical Epidemiology, 2003
- Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction.Hypertension, 2002
- The Kallikrein–Kinin System In HumansClinical and Experimental Pharmacology and Physiology, 2001
- Kinin receptors in pain and inflammationEuropean Journal of Pharmacology, 2001
- Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemiaThe FASEB Journal, 2000
- Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in ratsBrain Research, 1996
- Locomotor and passive avoidance deficits following occlusion of the middle cerebral arteryPhysiology & Behavior, 1995
- Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures.Proceedings of the National Academy of Sciences, 1995
- Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysisBritish Journal of Pharmacology, 1995